Inside Views: New Dutch Foundation To Address High Medicines Pricing Announces Plan To File Complaint With Competition Authority


The newly established Dutch Pharmaceutical Accountability Foundation has announced its first action to address unreasonably high medicines prices in the Netherlands. The Foundation will request the Netherlands Authority for Consumers and Markets to look into the price hike for the medicine chenodeoxycholic acid (CDCA) by the company Leadiant Biosciences Ltd (formerly Sigma-Tau). CDCA is used for the treatment of children and adults with cerebrotendinous xanthomatosis (CTX), a rare genetic metabolic disease that affects around 60 people in the Netherlands.
Fonte:http://www.ip-watch.org/2018/08/27/new-dutch-foundation-address-high-medicines-pricing-announces-plan-file-complaint-competition-authority/
Author: Intellectual Property Watch

WordPress Video Lightbox
Cerca